Nesuparib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nesuparib, covering 2025-04-03 to 2025-04-03. Get the full timeline:
Most recent: Clinical Trial Update: First-line Carboplatin and Paclitaxel in Combination With Pembrolizumab, Followed by Maintenance Pembrolizumab With or Without Nesuparib, in Patients With Newly Diagnosed Advanced or Recurrent MMR-proficient (pMMR) Endometrial Cancer [Phase 2]